Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata or formatting for the study details page.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating a newer revision of the page's metadata. This update does not change the study details or user-facing information.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now displays a recruitment status notice 'No longer looking for participants' and adds user-help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also standardizes the label to 'Intervention/Treatment' and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a version update. This appears to be a small backend/content-management update rather than a change to the study details shown.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This release-level change reflects an updated document or page iteration.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision label v3.5.3 was added to the page, replacing the previous v3.5.2. This reflects a minor administrative update to the ClinicalTrials.gov record and does not change the study content or results.SummaryDifference0.1%

Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.